CIBC Asset Management Inc Sells 1,863 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CIBC Asset Management Inc reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.7% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 106,423 shares of the pharmacy operator’s stock after selling 1,863 shares during the quarter. CIBC Asset Management Inc’s holdings in Walgreens Boots Alliance were worth $993,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. State Street Corp boosted its holdings in shares of Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after buying an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC boosted its holdings in shares of Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after buying an additional 934,754 shares during the last quarter. Finally, FMR LLC boosted its holdings in shares of Walgreens Boots Alliance by 2.5% in the 3rd quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after buying an additional 80,525 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Down 3.3 %

Shares of WBA opened at $10.16 on Friday. The business’s 50-day moving average price is $10.37 and its 200-day moving average price is $9.70. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The stock has a market cap of $8.78 billion, a PE ratio of -0.99, a P/E/G ratio of 1.31 and a beta of 0.65. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same period in the prior year, the business posted $0.66 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on WBA shares. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Bank of America boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $12.63.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.